chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"face tingling"; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ("face tingling") in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PARAESTHESIA ("face tingling"). At the time of the report, PARAESTHESIA ("face tingling") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Redness left arm, body aches and chills with fatigue 10/18/14. Fatigue and sweating 10/19/14. Redness gradually increased from 10-17-14 to 10-20-14.
Cold tingles in body immediately after injection, fatigued in an hour, high fever of 105.0 and chills from 12:40am 9/15 until current 2:07pm; fluctuating fever ranging from 101.0 - 105.0 F with chills, fatigue, strong headache and muscle pain. Took an Advil at 1:00pm on 9/15 and felt some relief from body aches still currently have a 102.3 fever
Pt. reports approximately 2 hours after receiving vaccine developed headache that is still present today. Other descriptions includes not feeling right & unable to iron tablecloth that she was supposed to help sister with. After laying down got up feeling unusually strong and angry. Also having spasms in back and ovaries.
hives; swollen lips and arm; swelling in whole body; swollen lips and arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), LIP SWELLING (swollen lips and arm), SWELLING (swelling in whole body) and VACCINATION SITE SWELLING (swollen lips and arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included INSULIN and blood pressure medication for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced URTICARIA (hives), LIP SWELLING (swollen lips and arm), SWELLING (swelling in whole body) and VACCINATION SITE SWELLING (swollen lips and arm). At the time of the report, URTICARIA (hives), LIP SWELLING (swollen lips and arm), SWELLING (swelling in whole body) and VACCINATION SITE SWELLING (swollen lips and arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Had injection site pain from time of injection. 2 days later notice red rash. At day 5, rash is from elbow to shoulder. Slightly swollen, itchy, and warm to touch.
My symptoms came 12 days after my shot from the MMR. I first had swelling in my neck glands, then had a Measles rash on my face and back. Swelling and stiffness in the joints on my legs, groin and wrist, I could hardly walk for two days. I went to the doctor and he confimed I had a reaction to the MMR shot, so he gave me a cortisone shot.
Bad headache the day after, drowsiness. Bad dreams during daytime nap (R/T headache?).
recurrent acute embolic stroke noted on MRI brain. Received vaccine on 4/10. Seen in ER 4/11 with confusion. CT head negative and discharged home. Admitted 4/13 with worsening L weakness and fall at night. Acute stroke noted on MRI imaging.
I received the vaccine about an inch below the acromion process. I immediately felt burning and I mentioned to the Pharmacist that it has an unusual burn this year. I had increased soreness for the next three days and caught myself guarding the shoulder. By the next week, the soreness decrease but I started having right joint pain and difficulty with range of motion. I sought care with my PCM, on 11/30/2017, who referred me for an MRI. As of today, as still have pain at rest and with movement and I am waiting for the referral's processing in order to schedule the MRI.
feeling very weak; slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling very weak) and PAIN IN EXTREMITY (slightly sore arm) in a 91-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A-72021) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included WARFARIN, FINASTERIDE, CHLORIDE, FUROSEMIDE, POTASSIUM CHLORIDE (LASIX + K) and emuferel for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feeling very weak) and PAIN IN EXTREMITY (slightly sore arm). At the time of the report, ASTHENIA (feeling very weak) and PAIN IN EXTREMITY (slightly sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Dose 1 on 26Jan2021: Sore left arm at injection site; persisted for approx. 40 hours. Slight brain fog - difficulty completing basic mental math (addition/subtraction with values less than 50); persisted for approx. 12 hours.  Dose 2 on 16Feb2021: Sore left arm at injection site; persisted for approx. 30 hours. Low-level headache focused behind my eyes; effectively treated twice with Tylenol and later with Ibuprofen; onset within 1.5 hours of injection; persisted for approx. 12 hours.
received Infanrix vaccination instead of Boostrix; Inappropriate age at vaccine administration; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received DTPa (Infanrix) (batch number 49TM3, expiry date 28th May 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th October 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 15th October 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The 12 years old patient received Infanrix vaccination instead of Boostrix vaccine, which led to wrong vaccine administered and inappropriate age at vaccine administration. At the time of call, the patient had not received Boostrix vaccine. The reporter did not consent to follow-up.
This spontaneous report was received from a nurse, concerning unspecified patients of unknown gender and age. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On unspecified dates between 05-APR-2017 and 01-MAY-2017, the patients were vaccinated with improperly stored doses of GARDASIL 9 (dose, frequency and route were not reported) lot # M037770 with expiration date of 01-JUN-2019, for prophylaxis. The temperature excursion of the GARDASIL 9 was 35°F for a time frame of 44 minutes and 48.7°F for a time frame of 1 hour and 15 minutes; Also, a previous temperature excursion occurred at 35.2°F for a time frame of 362 minutes (6 hours and 2 minutes). No adverse effects were reported. Data logger was involved. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA001159.
No additional AE reported.; Pharmacy intern reported patient received their first dose of VARIVAX at 1 year old and recently received their second dose of VARIVAX at 19 years old.; This spontaneous report was received from a pharmacy intern referring to a 19-year-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported.   On an unknown date (reported as " the patient at 1 year old"), the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection for prophylaxis (dose, strength, lot #, expiration date and route of administration were not provided). On 11-AUG-2022 (also reported as "the patient at 19 year old"), the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection for prophylaxis (lot # T041686, expiration date: 10-DEC-2022, dose, strength and route of administration were not provided) (inappropriate schedule of product administration). No additional adverse event (AE) was reported (no adverse event).
Covid Symptoms: Chills, Body Aches, Fever, Sweating while cold. Slept for 14 hours. Symptoms lasted from 8pm-4pm the next day.
Information has been received from a pharmacist referring to two patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On unknown dates each of the patients were vaccinated with a dose of ZOSTAVAX (strength, dose, dose number, lot #, route and application site were not reported). Concomitant therapy was not reported. Since unknown date, about one year after receiving ZOSTAVAX injection the patients developed shingles. The outcome of shingles was unknown. The causality was not reported. Additional information has been requested.
3/6/21  This is a 32-year-old female who is receiving her first Johnson & Johnson Covid vaccine and shortly afterwards developed some throat itching and tightness.  She was given a milligram of epinephrine by intramuscular injection by retired emergency physician there and then transported by ambulance here for further evaluation.  Says her tongue felt a little swollen as well but she denies any respiratory symptoms.  Her voice sounds crackly to her.  She denies any pruritus or rashes.  She has had multiple allergic reactions to medications in the past but never having to be admitted overnight.  One episode however did occur while she was hospitalized and receiving treatment.  She has never had to be intubated.  She has had isolated urticaria without oral or throat symptoms and vice versa.  At this point she says she does feel somewhat better. She is given IV dexamethasone and observed here.  At 1 point she complained of it complaint complained of it feeling like a tightening in the back of her throat was worsening.  She is given an additional intramuscular dose of epinephrine with epinephrine and on reexamination had no significant change in physical findings or her phonation.  This occurred again and she was given viscous lidocaine with minimal improvement in her symptoms.  After several hours of observation without objective worsening but continued complaint of feeling increasing tightness in her throat, CT imaging of the neck is performed to assess the soft tissue structures.  No abnormalities or indication of significant retropharyngeal or paralaryngeal edema or airway compromise present. Given the possibility of some laryngeal muscle or parapharyngeal muscle spasm as him, she was given Flexeril.  After some discussion with her I did indicate to her that I felt it would be safe to return home but offered admission for observation as well.  She indicated she was comfortable returning home for continued observation.  She will be continued on steroids and antihistamines and is given additional Flexeril by prescription if this does seem to help her symptoms.  If no improvement over the next 2 to 3 days and follow-up either with her primary providers through facility or Dr.  3/7/21: Return to ED. The patient is in no respiratory distress.  She has no wheezing.  On physical exam her throat lips and tongue look fine.  I think she is not a had another allergic reaction, rebounded from yesterday.  She is not on any type of steroids sinus syndrome with some Decadron.  And she is allergic to Benadryl but she can take Claritin if she wants.  Her CBC and chemistry were normal.  I went back to evaluate her and she still getting fluids and now she is complaining of shooting pain down her left leg from the EpiPen.  Again she has this regional complex pain syndrome that could be part of that but there is nothing I can do for this at this time.  In terms of her allergic reaction she feels much better her throat feels normal.  We will send her out with prescription for Decadron and EpiPen and if she gets worse she will come back and will follow up admit her.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 20-NOV-2015, the patient was vaccinated at health center with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 29-NOV-2016, the patient was treated at health center for the onset of a vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Patient's mother reported that he had "horrible diarrhea 1 hour after receiving his H1N1 Booster". He had diarrhea 3-4 times that day.
L deltoid distal tendonitis resulting in pain with shoulder extension, internal and external rotation. Improved but not resolved following 8 weeks of physical therapy.
Beginning at 5 p.m. the day of the vaccine, patient noticed itching and red rash under neck, and  on upper chest. In the middle of the night, patient awoke with itching and noted that rash had spread over more of upper chest and into left axillary area. She took Benadryl which helped the itch. Rash disappeared after 2-3 days.
Extremely dry skin; Throat closing increasing; Flaking skin; This is a spontaneous report from a contactable pharmacist. A 66-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Not known) via an intramuscular route in the left arm on 25Feb2021 at 19:30 (at the age of 66-years-old) for COVID-19 immunisation. The patient's medical history included asthma. The patient had Hydromorphone allergic reaction to first Shingrex vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included Asthma inhalers (MANUFACTURER UNKNOWN) for unknown indications from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 07Mar2021, the patient had extremely dry flaking skin, throat closing increasing over 3-day period. The patient was treated with oral prednisone 20 mg twice in a day for asthma attack. The clinical outcome of the events, extremely dry flaking skin, throat closing was resolving. Information about lot/batch number cannot be obtained. No further information is expected.
I was contacted on 4/18 at 730p by one of our volunteer vaccinators regarding the vaccination event on 4/17. At that event, she vaccinated an individual and expressed concern that the needle had not retracted and was lodged in the deltoid muscle. Upon further investigation, it had fully retracted as intended and no further workup was necessary. However, during our conversation on 4/18, she expressed concern that she had not known how to retract the needle during her first vaccination and had capped the needle. After thinking about this situation on 4/18, she was concerned that she believes she used the same needle to vaccinate the 2nd individual (i.e. the person who there was initial concern about a needle being lodged in the deltoid). Dr. (Name) is not aware of the name of either individual. Given these concerns, we will need to identify the individual, contact them, undergo the protocol for needlstick injury, and also vaccinate them if they are open to another vaccination. The plan is to review the encounter forms to find the two individuals and compare them against the scheduled appointments. Once identified, we will ask the source patient to undergo lab draws (either at HD or their urgent care) as well as ask the injured patient to undergo baseline labs.  ** Update**  Patient scheduled for vaccination on 4/26 Source patient negative for HIV, HepC Ab. HBsAg pending
feels like palpitation; mouth flu; sore arm; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (feels like palpitation), INFLUENZA (mouth flu), PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and CHILLS (chills) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939902 and 020F21A) for COVID-19 vaccination.     Concurrent medical conditions included Tourette's syndrome and Bipolar disorder. Concomitant products included QUETIAPINE FUMARATE (SEROQUEL), AMITRIPTYLINE, FLUOXETINE HYDROCHLORIDE (PROZAC) and OMEPRAZOLE for an unknown indication.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (feels like palpitation), INFLUENZA (mouth flu), PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and CHILLS (chills). At the time of the report, PALPITATIONS (feels like palpitation), INFLUENZA (mouth flu), PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            Patient was not allergic to food or medications Treatment medication were not reported.  Patient after getting the vaccine felt like palpitation, mouth flu, sore arm, fever and chills.
pt recvd vax & was dx w/ allergix rxn possibly to hbv; pt exp rash & was seen by ER MD; final dx--anaphylaxis rxn 2nd to insect bite.
Within minutes of receiving vaccine, pt verbalized feeling dizzy with a headache. Pt became pale and diaphoretic. Pt's lower extremities were elevated, ice pack applied to back of the neck and vital signs obtained. Juice and crackers were given. Within several minutes, Pt verbalized symptoms resolved and was ready to go home. Pt will lie down to receive second dose of Pfizer vaccine.
HIVES, INSIDE MOUTH SWELLING, COUGHING, TOOK BENADRYL, HIVES, SUBSIDED, COUGHING CONTINUED, HEART RATE INCREASED LATER IN EARLY HOURS OF 09/07/2014, HIVES STILL PRESENT CALLED 911.
One day after receiving my first dose of the Pfizer COVID-19 vaccine, I fainted and felt like I was dying. I was taken to the ER via ambulance.
This spontaneous report was received from a pharmacy technician, refers to multiple unspecified patients of unknown ages and genders. Concurrent condition and medical history were not reported. On an unknown date, the patients were vaccinated with a dose of improperly stored of ROTATEQ lot # J015063, expiration date 24-OCT-2015 (strength, dose #, dose, route of administration, anatomical location were not reported). There was not a product quality complaint involved. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Allergic reaction and hypersensitivity after the vaccine was administrated. The mother of the patient stated that the kid had hives all over his body, a rash and a lot of itching the day after the vaccine was administrated.
Day 1 and next day or so, slight soreness at injection site and tiredness.  5 days later nausea and diarrhea  and severe joint pain. Was pretty miserable. Slept a lot. Felt better next day, but not great.
adverse event with our temperature data logger; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (adverse event with our temperature data logger) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse event with our temperature data logger). At the time of the report, VACCINATION COMPLICATION (adverse event with our temperature data logger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  Treatment medication was not provided by the reporter   Reporter did not allow further contact
pt recvd vax; started feeling bad,getting weak,no appetite,woke up w/ swelling & redness of face;marked swelling of upper eyelids & face w/ erythema;
30NOV92 recvd flu vax; 10DEC92 Bell's Palsey;
Started as small rash on hands the morning after the vaccination, started having chills, headache, backache, and fever of 101.4 around 11:00 AM
Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH Significant for dementia, vitamin d deficiency, hypercholesterolemia, HTN. Pt was under the care of home health. No notes regarding death or recent illness. Pt was 88 years of age at time of death.
several passing of what appear to be blood and tissue; several passing of what appear to be blood and tissue; Extreme abdominal pain and cramping; hot flashes; sweating; nausea; ear ringing; This is a spontaneous report from a contactable consumer (patient) via COVAES. A 42-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL3302) via an unspecified route of administration in the right arm on 30Mar2021 at 12:15 (at 42-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa from an unknown date. Prior to vaccination the patient was not diagnosed with COVID-19 and had not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included citalopram hydrobromide (CELEXA), bupropion hydrochloride (WELLBUTRIN), alprazolam (XANAX), and zolpidem tartrate (AMBIEN), all from unknown dates for unknown indications. The patient experienced extreme abdominal pain and cramping about 2 hours after vaccination, followed by several passing of what appeared to be blood and tissue on 30Mar2021 at 14:30. The cramps were also accompanied by hot flashes, sweating, nausea, and ear ringing. The patient reported symptoms lasted 12 hours. No treatment was received for the events. The clinical outcomes of the events were recovering. Since vaccination the patient had not been tested for COVID-19.